Growth Metrics

Nu Skin Enterprises (NUS) Common Equity (2016 - 2025)

Nu Skin Enterprises' Common Equity history spans 17 years, with the latest figure at $805.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 23.61% year-over-year to $805.2 million; the TTM value through Dec 2025 reached $805.2 million, up 23.61%, while the annual FY2025 figure was $805.2 million, 23.61% up from the prior year.
  • Common Equity for Q4 2025 was $805.2 million at Nu Skin Enterprises, up from $799.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $941.0 million in Q2 2022 and bottomed at $651.5 million in Q4 2024.
  • The 5-year median for Common Equity is $832.1 million (2022), against an average of $834.3 million.
  • The largest annual shift saw Common Equity decreased 23.36% in 2024 before it grew 23.61% in 2025.
  • A 5-year view of Common Equity shows it stood at $912.8 million in 2021, then decreased by 1.7% to $897.3 million in 2022, then decreased by 8.4% to $822.0 million in 2023, then dropped by 20.74% to $651.5 million in 2024, then increased by 23.61% to $805.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Common Equity are $805.2 million (Q4 2025), $799.8 million (Q3 2025), and $787.8 million (Q2 2025).